skin and skin structure infections
Rural and Black Patients See Worse Outcomes for Diabetic Foot Ulcers
Rural patients and patients who are Black have a higher risk for major amputation from a diabetic foot ulcer than ...
MARCH 28, 2023
FDA Grants Pediatric Indication for Dalvance
The FDA granted a new indication to dalbavancin for the treatment of acute bacterial skin and skin structure ...
JULY 26, 2021
FDA Approves Nuzyra for CABP and ABSSSIs
The FDA approved omadacycline (Nuzyra, Paratek) to treat community-acquired bacterial pneumonia and acute bacterial ...
OCTOBER 4, 2018
FDA Committee Recommends Approval of Omadacycline
The FDA Antimicrobial Drugs Advisory Committee voted in favor of the approval of IV and oral omadacycline (Paratek ...
AUGUST 10, 2018
Baxdela for SSSIs Now Available
The oral and IV formulations of Baxdelafor the treatment of adults with acute bacterial skin and skin structure ...
JANUARY 30, 2018
FDA Approves Baxdela for Acute Bacterial Skin and Skin Structure Infections
Delafloxacin is a fluoroquinolone that exhibits activity against both gram-positive and gram-negative pathogens, ...
JUNE 26, 2017
